Larvol Delta - ASLAN-Pharmaceuticals-Provides-TREKDX-Study-Update-and-Highlights-Potential-of-Eblasakimab-in-DupilumabExperienced-Atopic-Dermatitis-Patients

eblasakimab (ASLAN004) - ASLAN Pharma, Zenyaku Holdings

https://www.globenewswire.com/news-release/2024/03/11/2843626/0/en/ASLAN-Pharmaceuticals-Provides-TREK-DX-Study-Update-and-Highlights-Potential-of-Eblasakimab-in-Dupilumab-Experienced-Atopic-Dermatitis-Patients.html

Mar 11, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next